Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with refractory inflammatory bowel disease or concomitant immune mediated disease or extra-intestinal manifestations: A Multi-Center Canadian Study Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Solitano, V
  • Ogunsakin, RE
  • Yuan, Yuhong
  • Bernstein, CN
  • Bessisow, T
  • Bressler, B
  • Hoentjen, F
  • van Lierop, L
  • Leung, Y
  • Ma, C
  • Marshall, JK
  • Narula, N
  • Alahmari, M
  • Mccurdy, J
  • Murthy, S
  • Panaccione, R
  • Milgrom, R
  • Rosenfeld, G
  • Silverberg, M
  • Jairath, V

publication date

  • January 22, 2025